A research paper, whose co-author is Natalia Porębska from our Department was published in the Molecular Biomedicine. The paper describes engineering of FGF1 for uncoupling of this growth factor from mitogenic activity towards is potential anti-diabetic agent. The full text of publication can be found here: https://link.springer.com/article/10.1186/s43556-025-00398-w